The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

Meletios A Dimopoulos; Adrían Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; Jeffrey A. Zonder; Carlos M. de Castro; Zvenyslava Masliak; Donna Reece; Marta Olesnyckyj; Zhinuan Yu; Donna M. Weber

doi:10.1002/cncr.25139

Related publications

Article2008

The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function

D. Weber, Andrew Spencer, M. Wang, C. Chen, Michel Attal, Rubén Niesvizky, Martin Prince, Zhinuan Yu, Robert Knight, Meletios A Dimopoulos

Corrigendum2014

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

David S. Siegel, Paul G. Richardson, Meletios A Dimopoulos, Philippe Moreau, C Mitsiades, D. Weber, Jennifer Houp, Christine K. Gause, Scott Vuocolo, Joe Eid, Thorsten Graef, Kenneth C. Anderson

Article2007

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios A Dimopoulos, Andrew Spencer, Michael Attal, H. Miles Prince, Jean‐Luc Harousseau, Anna Dmoszyńska, Jesús F. San Miguel, Andrzej Hellmann, Thierry Façon, Robin Foà, Alessandro Corso, Zvenyslava Masliak, Marta Olesnyckyj, Zhinuan Yu, John Patin, Jerome B. Zeldis, Robert Knight

Article2016

Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma

Flora Zagouri, Μαρία Ρούσσου, Efstathios Kastritis, Maria Gavriatopoulou, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Despoina Kalapanida, Dimitrios Christoulas, Magdalini Migkou, Evangelos Terpos, Meletios A Dimopoulos

Article2009

Lenalidomide plus Dexamethasone Has Similar Tolerability and Efficacy in Treatment of Relapsed/Refractory Multiple Myeloma Patients with or without History of Neuropathy.

Michel Delforge, Thierry Façon, Marie‐Laure Casadebaig Bravo, Meletios A Dimopoulos